The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

被引:2
作者
Stella, Giulia M. [1 ,2 ]
Marchio, Caterina [3 ,4 ]
Bari, Elia [5 ]
Ferrarotti, Ilaria [1 ,2 ]
Bertuccio, Francesco R. [1 ,2 ]
Di Gennaro, Antonella [2 ]
Abbott, David Michael [6 ]
Putignano, Paola [1 ,2 ]
Campo, Ilaria [2 ]
Torre, Maria Luisa [5 ]
Corsico, Angelo G. [1 ,2 ]
机构
[1] Univ Pavia, Dept Internal Med & Med Therapeut, Med Sch, I-27100 Pavia, Italy
[2] IRCCS Policlin San Matteo, Cardiothorac & Vasc Dept, Unit Resp Dis, I-27100 Pavia, Italy
[3] Univ Turin, Dept Med Sci, I-10124 Turin, Italy
[4] FPO IRCCS Candiolo Canc Inst, Pathol Unit, Str Provinciale 142, I-10060 Candiolo, Italy
[5] Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2-3, I-28100 Novara, Italy
[6] Univ Pavia, Dept Surg Pediat & Diagnost Sci, I-27100 Pavia, Italy
关键词
malignant pleural mesothelioma; genetics; microenvironment; targeted therapies; EXTRACELLULAR VESICLES; CELL NICHE; PROTEOMIC ANALYSIS; DNA-REPAIR; CANCER; HYPOXIA; EXPRESSION; EXOSOMES; CLASSIFICATION; IDENTIFICATION;
D O I
10.3390/ijms24043496
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MPM has a uniquely poor somatic mutational landscape, mainly driven by environmental selective pressure. This feature has dramatically limited the development of effective treatment. However, genomic events are known to be associated with MPM progression, and specific genetic signatures emerge from the exceptional crosstalk between neoplastic cells and matrix components, among which one main area of focus is hypoxia. Here we discuss the novel therapeutic strategies focused on the exploitation of MPM genetic asset and its interconnection with the surrounding hypoxic microenvironment as well as transcript products and microvesicles representing both an insight into the pathogenesis and promising actionable targets.
引用
收藏
页数:21
相关论文
共 177 条
  • [21] Hypoxia, DNA repair and genetic instability
    Bristow, Robert G.
    Hill, Richard P.
    [J]. NATURE REVIEWS CANCER, 2008, 8 (03) : 180 - 192
  • [22] The application of cancer stem cell model in malignant mesothelioma
    Bronte, Giuseppe
    Procopio, Antonio Domenico
    Graciotti, Laura
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
  • [23] Exploiting tumour hypoxia in cancer treatment
    Brown, JM
    William, WR
    [J]. NATURE REVIEWS CANCER, 2004, 4 (06) : 437 - 447
  • [24] Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
    Bueno, Raphael
    Stawiski, Eric W.
    Goldstein, Leonard D.
    Durinck, Steffen
    De Rienzo, Assunta
    Modrusan, Zora
    Gnad, Florian
    Nguyen, Thong T.
    Jaiswal, Bijay S.
    Chirieac, Lucian R.
    Sciaranghella, Daniele
    Dao, Nhien
    Gustafson, Corinne E.
    Munir, Kiara J.
    Hackney, Jason A.
    Chaudhuri, Amitabha
    Gupta, Ravi
    Guillory, Joseph
    Toy, Karen
    Ha, Connie
    Chen, Ying-Jiun
    Stinson, Jeremy
    Chaudhuri, Subhra
    Zhang, Na
    Wu, Thomas D.
    Sugarbaker, David J.
    de Sauvage, Frederic J.
    Richards, William G.
    Seshagiri, Somasekar
    [J]. NATURE GENETICS, 2016, 48 (04) : 407 - +
  • [25] A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
    Burk, Ulrike
    Schubert, Joerg
    Wellner, Ulrich
    Schmalhofer, Otto
    Vincan, Elizabeth
    Spaderna, Simone
    Brabletz, Thomas
    [J]. EMBO REPORTS, 2008, 9 (06) : 582 - 589
  • [26] The hematopoietic stem cell niche in homeostasis and disease
    Calvi, Laura M.
    Link, Daniel C.
    [J]. BLOOD, 2015, 126 (22) : 2443 - 2451
  • [27] BAP1 and cancer
    Carbone, Michele
    Yang, Haining
    Pass, Harvey I.
    Krausz, Thomas
    Testa, Joseph R.
    Gaudino, Giovanni
    [J]. NATURE REVIEWS CANCER, 2013, 13 (03) : 153 - 159
  • [28] MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?
    Caruso, S.
    Bazan, V.
    Rolfo, C.
    Insalaco, L.
    Fanale, D.
    Bronte, G.
    Corsini, L. R.
    Rizzo, S.
    Cicero, G.
    Russo, A.
    [J]. ONCOGENESIS, 2012, 1 : e32 - e32
  • [29] Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease
    Cavalleri, Tommaso
    Angelici, Laura
    Favero, Chiara
    Dioni, Laura
    Mensi, Carolina
    Bareggi, Claudia
    Palleschi, Alessandro
    Rimessi, Arianna
    Consonni, Dario
    Bordini, Lorenzo
    Todaro, Aldo
    Bollati, Valentina
    Pesatori, Angela Cecilia
    [J]. PLOS ONE, 2017, 12 (05):
  • [30] Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
    Cedres, Susana
    Ponce-Aix, Santiago
    Zugazagoitia, Jon
    Sansano, Irene
    Enguita, Ana
    Navarro-Mendivil, Alejandro
    Martinez-Marti, Alex
    Martinez, Pablo
    Felip, Enriqueta
    [J]. PLOS ONE, 2015, 10 (03):